Genscript Probio
GenScript ProBio (ProBio) is the biologics and cell & gene therapy contract development and manufacturing organization (CDMO) segment of GenScript Biotech Corporation (HKEX 1548), operating from sites in the United States, the Netherlands, South Korea, Hong Kong, Shanghai, Nanjing and Zhenjiang. It provides end-to-end drug-discovery-to-commercialization services covering antibody and ADC discovery, antibody engineering and humanization, developability assessment, cell line development, bioanalytical and bioassay services, process development, and cGMP clinical and commercial manufacturing of recombinant proteins, plasmid DNA, lentiviral and AAV viral vectors, mRNA and cell therapies, having supported more than 150 IND approvals since 2017. ProBio is a laboratory and manufacturing services business rather than a software vendor: it publishes no developer portal, no API reference and no machine-readable contract, and customer engagement runs through a quote request form and an authenticated customer account area.
Genscript Probio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Pharmaceuticals, and Contract Manufacturing.
Genscript Probio’s developer surface includes support, signup flow, engineering blog, and 10 more developer resources.
Kin Score
Pricing Plans 1
Published pricing tiers and plan structures.
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 3
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.